Resistance to ceftaroline - 2018 review
- 1. Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce, Poland
- 2. Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce,
- 3. Faculty of Medical Science, Higher School of Economics, Law and Medical Science of Professor Edward Lipiński, Kielce, Poland
Description
Ceftaroline is a new fifth generation cephalosporin, active mostly against Gram-positive cocci, e.g. Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus). It is used in treating acute bacterial skin and skin structure infections, community acquired respiratory tract infections and methicillin-resistant S. aureus bacteremia. The main resistance mechanisms of bacteria to β-lactam antibiotics, including ceftaroline, are mutations in PBP2a, PBP3 and PBP4. Clinically significant resistance has been noted among both archived and newly-isolated strains in a laboratory test using serial passages. Ceftaroline-resistant strains have also been found in patients suffering from cystic fibrosis, ventilator-associated pneumonia and infectious endocarditis. Irresponsible antibiotic treatment using ceftaroline or other antibiotics (due to a possibility of a cross-resistance) can lead to the spread of ceftaroline resistance and, consequently, its loss of value.
Files
EJBR2018v8i3art112-120.pdf
Files
(141.0 kB)
Name | Size | Download all |
---|---|---|
md5:90c755ce62b51d2cab2d828359cdf483
|
141.0 kB | Preview Download |
Additional details
Related works
- Is cited by
- 2449-8955 (ISSN)